JP2017508737A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017508737A5 JP2017508737A5 JP2016552579A JP2016552579A JP2017508737A5 JP 2017508737 A5 JP2017508737 A5 JP 2017508737A5 JP 2016552579 A JP2016552579 A JP 2016552579A JP 2016552579 A JP2016552579 A JP 2016552579A JP 2017508737 A5 JP2017508737 A5 JP 2017508737A5
- Authority
- JP
- Japan
- Prior art keywords
- mcg
- csf
- days
- analog
- retinoid agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461941233P | 2014-02-18 | 2014-02-18 | |
| US61/941,233 | 2014-02-18 | ||
| PCT/US2015/016447 WO2015126989A1 (en) | 2014-02-18 | 2015-02-18 | Compositions and methods for treating neutropenia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017508737A JP2017508737A (ja) | 2017-03-30 |
| JP2017508737A5 true JP2017508737A5 (enExample) | 2018-03-29 |
Family
ID=53878925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552579A Pending JP2017508737A (ja) | 2014-02-18 | 2015-02-18 | 好中球減少症の治療用の組成物及び方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10286039B2 (enExample) |
| EP (1) | EP3107533A4 (enExample) |
| JP (1) | JP2017508737A (enExample) |
| KR (1) | KR20160113302A (enExample) |
| CN (1) | CN106413701A (enExample) |
| AU (1) | AU2015219038B2 (enExample) |
| CA (1) | CA2937340C (enExample) |
| MX (1) | MX2016010699A (enExample) |
| RU (1) | RU2016136833A (enExample) |
| WO (1) | WO2015126989A1 (enExample) |
| ZA (1) | ZA201605109B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102083046B1 (ko) | 2012-06-07 | 2020-02-28 | 칠드런＇스 하스피틀 로스 앤젤레스 | 레티노이드 작용제를 이용하여 호중구감소증을 치료하기 위한 방법 |
| MX2016010699A (es) | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
| CN107130026B (zh) * | 2017-05-15 | 2018-03-09 | 新疆医科大学第四附属医院 | 一种结直肠癌诊断和治疗效果评价相关的基因 |
| WO2019079339A1 (en) * | 2017-10-18 | 2019-04-25 | Avalon Flaviviral Therapeutics (Hk) Limited | COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTIVIRAL THERAPY |
| CN112390731B (zh) * | 2020-11-16 | 2022-11-25 | 成都大学 | 一种具有多靶点的维甲酸类衍生物及其制备方法与应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5691196A (en) | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
| US5965606A (en) | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| EP0957918A1 (en) | 1996-12-19 | 1999-11-24 | American Cyanamid Company | Method of treating or inhibiting neutropenia |
| MXPA03002045A (es) | 2000-09-08 | 2003-07-24 | Amgen Inc | Composiciones analogas de factor estimulador de colonias de granulocitos y metodos para su elaboracion. |
| US7119061B2 (en) | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
| AU2003902308A0 (en) | 2003-05-14 | 2003-05-29 | Diagnose It Pty Ltd | A method and system for the monitoring of medical conditions |
| KR20060018851A (ko) * | 2003-05-16 | 2006-03-02 | 교와 핫꼬 고교 가부시끼가이샤 | 조직 파괴를 수반하는 질환의 예방 및/또는 치료제 |
| EP1621191A1 (en) | 2004-07-29 | 2006-02-01 | Werner Bollag | Treatment of inflammatory diseases by RXR Antagonists |
| JP2008509928A (ja) | 2004-08-13 | 2008-04-03 | アノーメド インコーポレイテッド | 前駆／幹細胞を動員するためのケモカインの組み合わせ |
| ATE476981T1 (de) | 2004-12-02 | 2010-08-15 | Venus Remedies Ltd | Zusammensetzungen zur bekämpfung von beta- lactamase-vermittelter antibiotischer resistenz mittels beta-lactamase-hemmern für injektionen |
| US20090111786A1 (en) | 2004-12-03 | 2009-04-30 | Glass Christopher K | Compounds that Prevent Macrophage Apoptosis and Uses Thereof |
| TR201819157T4 (tr) | 2006-05-16 | 2019-01-21 | Io Therapeutics Llc | Kemoterapi Ve Veya Radyasyon Terapisinin Yan Etkilerinin Tedavisinde Kullanıma Yönelik Rar Antagonisti Veya Ters Agonisti |
| EP2143428B1 (en) | 2007-03-30 | 2015-11-04 | TMRC Co., Ltd. | Tamibarotene capsule preparation |
| WO2009070844A1 (en) | 2007-12-06 | 2009-06-11 | Csl Limited | Method of inhibition of leukemic stem cells |
| US8580516B2 (en) * | 2008-09-05 | 2013-11-12 | University Of Chicago | Methods and compositions for direct detection of DNA damage |
| CN102612371B (zh) | 2009-10-19 | 2014-03-19 | 莱拉营养食品有限公司 | 含有多聚乙酰的提取物，分馏物和混合物及它们的应用 |
| RU2446173C1 (ru) | 2010-08-13 | 2012-03-27 | Зао "Биокад" | Новый функционально активный, высокоочищенный стабильный конъюгат гранулоцитарного колониестимулирующего фактора (г-ксф) с полиэтиленгликолем с пролонгированным биологическим действием, пригодный для медицинского применения, и иммунобиологическое средство на его основе |
| CN102380090A (zh) * | 2010-08-31 | 2012-03-21 | 健能隆医药技术（上海）有限公司 | G-csf二聚体在治疗嗜中性粒细胞减少症中的应用 |
| CA2826386C (en) * | 2011-02-08 | 2020-04-28 | FUJIFILM Cellular Dynamics, Inc. | Hematopoietic precursor cell production by programming |
| JP6242868B2 (ja) | 2012-05-08 | 2017-12-06 | リセラ・コーポレイションＬｙｃｅｒａ Ｃｏｒｐｏｒａｔｉｏｎ | ＲＯＲγのアゴニストとしての使用のためおよび疾患の処置のためのテトラヒドロ［１，８］ナフチリジンスルホンアミドおよび関連化合物 |
| JP2015518872A (ja) | 2012-06-06 | 2015-07-06 | フォンダッツィオーネ・テレソン | アロステリックシャペロンおよびその使用 |
| KR102083046B1 (ko) | 2012-06-07 | 2020-02-28 | 칠드런＇스 하스피틀 로스 앤젤레스 | 레티노이드 작용제를 이용하여 호중구감소증을 치료하기 위한 방법 |
| US20160172942A1 (en) | 2013-07-04 | 2016-06-16 | Linak A/S | Actuator system |
| MX2016010699A (es) | 2014-02-18 | 2017-10-11 | Children's Hospital Los Angeles | Composiciones y metodos para tratar neutropenia. |
-
2015
- 2015-02-18 MX MX2016010699A patent/MX2016010699A/es unknown
- 2015-02-18 CA CA2937340A patent/CA2937340C/en active Active
- 2015-02-18 CN CN201580009151.6A patent/CN106413701A/zh active Pending
- 2015-02-18 JP JP2016552579A patent/JP2017508737A/ja active Pending
- 2015-02-18 EP EP15751576.8A patent/EP3107533A4/en not_active Withdrawn
- 2015-02-18 US US15/119,339 patent/US10286039B2/en active Active
- 2015-02-18 RU RU2016136833A patent/RU2016136833A/ru not_active Application Discontinuation
- 2015-02-18 WO PCT/US2015/016447 patent/WO2015126989A1/en not_active Ceased
- 2015-02-18 KR KR1020167025068A patent/KR20160113302A/ko not_active Withdrawn
- 2015-02-18 AU AU2015219038A patent/AU2015219038B2/en not_active Ceased
-
2016
- 2016-07-21 ZA ZA2016/05109A patent/ZA201605109B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101636145B (zh) | 长期24小时经肠给予左旋多巴/卡比多巴 | |
| JP2021527092A5 (enExample) | ||
| JP2017508737A5 (enExample) | ||
| JP2013533858A5 (enExample) | ||
| JP2014528474A5 (enExample) | ||
| JP2014528901A5 (enExample) | ||
| JP2018520189A5 (enExample) | ||
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| IL292770A (en) | Formulations and dosages of polyethylene glycol-modified oricase | |
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| RU2016136833A (ru) | Композиции и способы для лечения нейтропении | |
| JP2016505050A5 (enExample) | ||
| CN1913902A (zh) | 使用喹硫平抗精神病药物治疗精神疾病 | |
| JP2023502053A5 (enExample) | ||
| JP2023011549A5 (enExample) | ||
| WO2020042719A1 (zh) | 肌苷在防治抑郁症中的应用 | |
| JP2023531930A5 (enExample) | ||
| CN1287855C (zh) | B型慢性肝炎治疗剂 | |
| JP2022526643A5 (enExample) | ||
| US8198293B2 (en) | Oxymatrine compositions and related methods for treating and preventing chronic infectious diseases | |
| JP2021091608A5 (enExample) | ||
| JP2012031141A (ja) | 骨髄異形性症候群を治療するための組成物および方法 | |
| JP2015520759A5 (enExample) | ||
| JP2025521501A5 (enExample) | ||
| RU2013155476A (ru) | Композиции и способы изменения фенотипов xlhed |